argus

Aarti Drugs Limited

NSE: AARTIDRUGSINE767A010163,809 Cr

Timeline

Time (IST)TypeMEventSrc
07 Mar, 01:12 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Acquisitionbse
07 Mar, 01:11 pmAarti Drugs Limited has informed the Exchange about General Updatesnse
02 Mar, 10:40 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Acquisitionbse
02 Mar, 10:34 pmAarti Drugs Limited has informed the Exchange about General Updatesnse
16 Feb, 06:25 pmAarti Drugs Limited has informed the Exchange about Cancellation of Schedule of Analyst / Institutional Investor Meetingsnse
10 Feb, 08:46 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
10 Feb, 08:46 pmAarti Drugs Limited has informed the Exchange about Transcriptnse
04 Feb, 07:04 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
04 Feb, 07:00 pmAarti Drugs Limited has informed the Exchange about Link of Recordingnse
03 Feb, 08:07 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
03 Feb, 08:06 pmAarti Drugs Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "Press Release on Q3& 9M FY26 financial ".nse
03 Feb, 08:02 pmAarti Drugs Limited has informed the Exchange about Investor Presentationnse
03 Feb, 08:01 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
03 Feb, 07:36 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Change in Managementbse
03 Feb, 07:33 pmAarti Drugs Limited has informed the Exchange about change in Managementnse
03 Feb, 07:24 pmAarti Drugs Ltd - 524348 - Corporate Action-Board approves Dividendbse
03 Feb, 07:16 pmAarti Drugs Limited has informed the Exchange that Record date for the purpose of Dividend is 09-Feb-2026.nse
03 Feb, 07:10 pmAarti Drugs Limited has informed the Exchange that Board of Directors at its meeting held on February 03, 2026, declared Interim Dividend of Rs. 2 per equity share.nse
03 Feb, 07:05 pmFinancial Results and Interim Dividendnse
03 Feb, 07:02 pmAarti Drugs Ltd - 524348 - Board Meeting Outcome for Outcome Of Board Meetingbse
03 Feb, 06:55 pmAarti Drugs Ltd - 524348 - Financials Results For The Quarter And Nine Months Ended December 31, 2025bse
29 Jan, 08:17 pmAarti Drugs Limited has informed the Exchange about Credit Ratingnse
29 Jan, 08:14 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
27 Jan, 05:44 pmAarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31, 2025 And Interim Dividend For The FY 2025-26, If Anybse
14 Nov, 06:46 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
14 Nov, 06:46 pmAarti Drugs Limited has informed the Exchange about Transcriptnse
10 Nov, 10:22 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
10 Nov, 10:22 pmAarti Drugs Limited has informed the Exchange about Link of Recordingnse
07 Nov, 08:45 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
07 Nov, 08:44 pmAarti Drugs Limited has informed the Exchange about Investor Presentationnse
07 Nov, 08:39 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 Nov, 08:39 pmAarti Drugs Limited has informed the Exchange regarding a press release dated 0 , , titled "Q2 & H1 FY26 Business & Financial Performance".nse
07 Nov, 02:55 pmAarti Drugs Ltd - 524348 - Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2025bse
07 Nov, 02:48 pmAarti Drugs Ltd - 524348 - Financial Results For The Quarter And Half Year Ended September 30 2025bse
07 Nov, 02:48 pmAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.nse
31 Oct, 08:25 pmAarti Drugs Ltd - 524348 - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 2025bse
09 Oct, 07:04 pmAarti Drugs Limited has informed the Exchange about Crisil ESG ratingnse
06 Oct, 11:44 pmAarti Drugs Ltd - 524348 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")bse
06 Oct, 11:44 pmAarti Drugs Limited has informed the Exchange about Action(s) taken or orders passednse
24 Sept, 08:48 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Change in Managementbse
24 Sept, 08:48 pmAarti Drugs Limited has informed the Exchange about re-appointment of Director and appointment of Secretarial Auditor at AGMnse
24 Sept, 08:35 pmAarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
24 Sept, 08:34 pmAarti Drugs Limited has informed the Exchange regarding 'Presentation made to the shareholders at 40th AGM'.nse
10 Sept, 02:35 pmAarti Drugs Ltd - 524348 - Closure Of Chlorosulfonation Process At PTSCL Section At T-150 Unit Pursuant To Voluntary Closure Directions Of MPCBbse
10 Sept, 02:35 pmAarti Drugs Limited has informed the Exchange about Action(s) taken or orders passednse
04 Sept, 07:05 pmAarti Drugs Ltd - 524348 - Commercialization Of Manufacturing Plant Located At Sayakhabse
04 Sept, 07:05 pmAarti Drugs Limited has informed the Exchange about Commencement of commercial production/operationsnse